Biotech Values

[DewDiligence]

MDT acquires Cardiocom (private) for $200M in cash:

http://online.wsj.com/article/SB10001424127887323446404579006692534107228.html

Cardiocom's products, such as home glucose monitors for diabetics and weight scales that help doctors detect early signs of worsening heart failure, could get a boost from a new health-law rule that penalizes hospitals when their patients return within a month of discharge.

…Medtronic says it will focus initially on tackling heart-failure, a disease it is familiar with from years of manufacturing implantable heart-rhythm devices.